Preparation and characterization of microspheres of ivabradine hydrochloride using natural, semi-synthetic, and synthetic polymers

Vemuri Akash


The present work was aimed to the development of controlled release formulations of esomeprazole and
dexlansoprazole to improve bioavailability. Both esomeprazole and dexlansoprazole are the proton-pump
inhibitor that suppresses gastric acid secretion by specific inhibition of the H+/K+-ATPase in the gastric parietal
cell. By acting specifically on the proton pump, esomeprazole and dexlansoprazole block the final step in acid
production, thus reducing gastric acidity.

Full Text:




  • There are currently no refbacks.